TP53 mutations affect the sensitivity of TIS cancer cells to BH3 mimetics, as p53 transcriptionally regulates BH3-only proteins and interacts with BCL-2 family proteins at the MOM [29, 103–105]. The gene discussed is BCL2; the disease is cancer.